Clindamycin Completed Phase 2 Trials for Rash Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00473083Systemic and Topical Treatments for Rash Secondary to Erlotinib in Lung Cancer